Treatment of experimental arthritis by inducing immune tolerance with human adipose‐derived mesenchymal stem cells

Abstract

Human AD-MSCs emerge as key regulators of immune tolerance by inducing the generation/activation of Treg cells and are thus attractive candidates for a cell-based therapy for RA.